Home › Compare › XRAPF vs CL

XRAPF vs CL: Dividend Comparison 2026

XRAPF yields 44444.44% · CL yields 2.43%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 XRAPF wins by $1.4802188700273396e+23M in total portfolio value
10 years
XRAPF
XRAPF
● Live price
44444.44%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.4802188700273396e+23M
Annual income
$147,369,615,738,581,320,000,000,000,000.00
Full XRAPF calculator →
CL
CL
● Live price
2.43%
Share price
$85.73
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.8K
Annual income
$5,401.96
Full CL calculator →

Portfolio growth — XRAPF vs CL

📍 XRAPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodXRAPFCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, XRAPF + CL cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
XRAPF pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XRAPF
Annual income on $10K today (after 15% tax)
$3,777,777.78/yr
After 10yr DRIP, annual income (after tax)
$125,264,173,377,794,110,000,000,000,000.00/yr
CL
Annual income on $10K today (after 15% tax)
$206.23/yr
After 10yr DRIP, annual income (after tax)
$4,591.67/yr
At 15% tax rate, XRAPF beats the other by $125,264,173,377,794,110,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XRAPF + CL for your $10,000?

XRAPF: 50%CL: 50%
100% CL50/50100% XRAPF
Portfolio after 10yr
$7.401094350136698e+22M
Annual income
$73,684,807,869,290,660,000,000,000,000.00/yr
Blended yield
99.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

XRAPF
No analyst data
Altman Z
-3.9
Piotroski
1/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+7.8% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XRAPF buys
0
CL buys
0
No recent congressional trades found for XRAPF or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricXRAPFCL
Forward yield44444.44% ✓2.43%
Annual dividend / share$2.00$2.08 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28.6% ✓
Portfolio after 10y$1.4802188700273396e+23M$40.8K ✓
Annual income after 10y$147,369,615,738,581,320,000,000,000,000.00 ✓$5,401.96
Total dividends collected$1.4797905017086652e+23M$18.0K ✓
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: XRAPF vs CL ($10,000, DRIP)

YearXRAPF PortfolioXRAPF Income/yrCL PortfolioCL Income/yrGap
1← crossover$4,455,144$4,444,444.44$11,012$312.01+$4.44M → XRAPF
2$1,855,294,292$1,850,527,287.41$12,196$412.95+$1855.28M → XRAPF
3$722,201,114,647$720,215,949,754.98$13,599$549.66+$722201.10M → XRAPF
4$262,786,638,114,837$262,013,882,922,164.10$15,288$736.64+$262786638.10M → XRAPF
5$89,382,811,928,504,960$89,101,630,225,722,080.00$17,353$995.28+$89382811928.49M → XRAPF
6$28,419,510,536,946,614,000$28,323,870,928,183,110,000.00$19,926$1,357.80+$28419510536946.59M → XRAPF
7$8,446,906,587,814,894,000,000$8,416,497,711,540,360,000,000.00$23,194$1,873.82+$8446906587814894.00M → XRAPF
8$2,346,953,255,508,951,600,000,000$2,337,915,065,459,989,300,000,000.00$27,439$2,621.52+$2346953255508951552.00M → XRAPF
9$609,599,312,292,179,560,000,000,000$607,088,072,308,785,000,000,000,000.00$33,088$3,727.38+$609599312292179607552.00M → XRAPF
10$148,021,887,002,733,950,000,000,000,000$147,369,615,738,581,320,000,000,000,000.00$40,806$5,401.96+$1.4802188700273396e+23M → XRAPF

XRAPF vs CL: Complete Analysis 2026

XRAPF — Stock

XRApplied Technologies Inc. engages in the development of augmented reality, virtual reality, and mixed reality technologies in Canada and France. Its products include Technology News App, which shares the latest in cutting edge immersive reality products, news, and developments; ARFlooring Made Easy, an app that can overlay flooring options into a photo of any space, so the consumer can see what the product will look like in their home; Balloon Pop, an educational and fun app for children; and Rifters AR Shooting Game, an AR-shooting and role-playing game. The company is headquartered in Vancouver, Canada.

Full XRAPF Calculator →

CL — Consumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this XRAPF vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XRAPF vs SCHDXRAPF vs JEPIXRAPF vs OXRAPF vs KOXRAPF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.